Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Centro de investigación
University of South Florida
Tampa, Estados UnidosPublicacións en colaboración con investigadores/as de University of South Florida (9)
2024
-
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473
-
Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data
World Allergy Organization Journal , Vol. 17, Núm. 7
2023
-
Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice: Methodology
World Allergy Organization Journal, Vol. 16, Núm. 2
2021
-
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial
Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 3, pp. 1020-1030.e10
-
Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 4, pp. 1041-1052
2018
-
A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk
Cancer Research, Vol. 78, Núm. 18, pp. 5419-5430
2017
-
Five-year Efficacy and safety of tocilizumab monotherapy in patients with rheumatoid arthritis who were methotrexate-And biologic-naive or free of methotrexate for 6 months: The ambition study
Journal of Rheumatology, Vol. 44, Núm. 2, pp. 142-146
2016
-
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond
PLoS Pathogens, Vol. 12, Núm. 7
2015
-
BRCA1 Circos: A visualisation resource for functional analysis of missense variants
Journal of Medical Genetics, Vol. 52, Núm. 4, pp. 224-230